Tian Junrui, Ma Jian
NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Cancer Research Institute and School of Basic Medical Science, Central South University, Changsha 410078, China.
Pharmaceutics. 2023 Aug 14;15(8):2138. doi: 10.3390/pharmaceutics15082138.
Tumor neoantigens are widely used in cancer immunotherapy, and a growing body of research suggests that microbes play an important role in these neoantigen-based immunotherapeutic processes. The human body and its surrounding environment are filled with a large number of microbes that are in long-term interaction with the organism. The microbiota can modulate our immune system, help activate neoantigen-reactive T cells, and play a great role in the process of targeting tumor neoantigens for therapy. Recent studies have revealed the interconnection between microbes and neoantigens, which can cross-react with each other through molecular mimicry, providing theoretical guidance for more relevant studies. The current applications of microbes in immunotherapy against tumor neoantigens are mainly focused on cancer vaccine development and immunotherapy with immune checkpoint inhibitors. This article summarizes the related fields and suggests the importance of microbes in immunotherapy against neoantigens.
肿瘤新抗原在癌症免疫治疗中被广泛应用,越来越多的研究表明微生物在这些基于新抗原的免疫治疗过程中发挥着重要作用。人体及其周围环境中充满了大量与机体长期相互作用的微生物。微生物群可以调节我们的免疫系统,帮助激活新抗原反应性T细胞,并在靶向肿瘤新抗原进行治疗的过程中发挥重要作用。最近的研究揭示了微生物与新抗原之间的相互联系,它们可以通过分子模拟相互交叉反应,为更多相关研究提供了理论指导。目前微生物在针对肿瘤新抗原的免疫治疗中的应用主要集中在癌症疫苗开发和免疫检查点抑制剂免疫治疗方面。本文总结了相关领域,并指出了微生物在针对新抗原的免疫治疗中的重要性。